DEBRA GARRISON: Open Payments
NPI 1427623008 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 25 payments from 15 companies in 2025. Trend: 2023 $236 · 2024 $357 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 4 | $106 |
| Sumitomo Pharma America, Inc. | 4 | $72 |
| Astellas Pharma US Inc | 2 | $49 |
| ABBVIE INC. | 2 | $36 |
| Octapharma USA, Inc. | 2 | $29 |
| Organon LLC | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: ZURZUVAE, MYFEMBREE, Veozah, FIBRYGA, NEXPLANON, Lynkuet, Qelbree, GEMTESA.
Industry payments across SC — which companies pay providers there.
